Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Turkey / NCT06969248
Active, not recruiting Not applicable

Program to Increase Fathers' Involvement in Infant Care

NCT06969248 · tracked via the Priya Life Science Turkey tracker
Sponsor
Selcuk University
Phase
Not applicable
Started
2025-01-01
Last updated
2025-05-13

Condition(s) studied

Randomised Controlled TrialPublic Health NursingChild Health

Investigational drug(s) / intervention(s)

Intervention Group

Intervention Group: Fathers will be provided with a total of 8 weeks of training and videos. The training will cover the role of fatherhood and its historical development, the developmental stages and care needs of babies, ways for fathers to participate in baby care and the benefits of participation, father-infant bonding and influencing factors, and paternal depression. Videos on the subject will be shared with fathers.

Study summary

Fathers participating in the study will be given an 8-week formality intervention. Participants will be shown 4-week infant care training records and then 4-week videos prepared on educational topics. The effect of the intervention will be determined annually by the mean scores of the Fathers' Participation in Infant Care Questionnaire, Father Infant Attachment Scale, and Edinburgh Postpartum Depression Scale.

Eligibility

Sex
MALE
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria * Having a healthy baby between 4-12 months old, * Being a first-time father, * Volunteering to participate in the study, * Having a smartphone Exclusion Criteria: * Being under 18 years old, * Having a psychiatric diagnosis.

Primary outcome measure(s)

  • Fathers' Involvement in Infant Care Questionnaire — 8 week
  • Father Infant Attachment Scale — 8 week
  • Edinburgh Postpartum Depression Scale — 8 week

Trial sites (1)

FacilityCityRegionStatus
Selcuk University Konya Turkey (Türkiye)

More Selcuk University trials in Turkey

Validation of a Virtual Reality Timed Up and Go Test in Adults With Chronic Non-Specific Low Back Pain Starting soon
Respiratory Muscle Strength and Endurance Cut-Offs in Multiple Sclerosis Starting soon
Effects of Laughter Therapy on Postpartum Mothers' Stress, Sleep, and Breastfeeding Enrolling by invitation
Validity and Reliability of Mixed Reality-Based Performance Tests in Overweight and Obese Adults Recruiting
Virtual Reality-Based Functional Mobility Tests in Older Adults Starting soon

Other trials for the same condition

Effect of a Mobile App for Obese Children on Eating Attitudes, Eating Awareness, and Healthy Eating Self-Efficacy Starting soon
The Effect of Carer Training on Pressure Ulcers in Palliative Patients Recruiting
Outcomes of a Game-based Educational Intervention: Healthy Kids Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06969248 on ClinicalTrials.gov ↗ ← All trials in Turkey